Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.9196
+0.0304 (3.42%)
At close: Sep 17, 2026, 4:00 PM EDT
0.9199
+0.0003 (0.03%)
After-hours: Sep 17, 2026, 4:58 PM EDT

Milestone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
13020515672169276
Market Cap Growth
-32.81%31.26%117.39%-57.49%-38.80%38.33%
Enterprise Value
1011801344795151
Last Close Price
0.892.022.361.673.966.55

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
54.16132.73-71.9133.8318.43
PB Ratio
6.884.9111.894.292.552.46
P/TBV Ratio
6.974.9111.894.292.552.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
41.88116.31-47.1918.9010.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
7.791.404.173.090.040.01
Net Debt / Equity Ratio
-1.58-1.14-1.13-0.85-0.94-1.01
Net Debt / EBITDA Ratio
0.370.770.360.231.042.64
Net Debt / FCF Ratio
0.470.960.520.311.183.41
Asset Turnover
0.020.02-0.010.050.11
Quick Ratio
7.877.838.799.3410.7216.92
Current Ratio
8.138.019.1010.1111.7017.55
Return on Equity (ROE)
-35522.62%-229.65%-277.55%-143.61%-65.26%-33.52%
Return on Assets (ROA)
-42.77%-41.09%-34.92%-51.01%-38.36%-19.95%
Return on Capital Employed (ROCE)
-49.20%-62.40%-62.50%-89.80%-87.30%-38.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-66.21%-30.73%-26.56%-83.00%-34.52%-15.50%
FCF Yield
-48.58%-24.05%-18.48%-64.72%-31.18%-12.02%
Buyback Yield / Dilution
-77.94%-34.84%-44.82%-1.19%-1.47%-42.56%
SEC Filings: 10-K · 10-Q